Could China’s New Ozempic-like Drugs Beat Out Current Weight-Loss Medications?
GLP-1 drugs currently being tested in China target complications associated with obesity such as heart disease, fatty liver disease and type 2 diabetes
GLP-1 drugs currently being tested in China target complications associated with obesity such as heart disease, fatty liver disease and type 2 diabetes
What's Your Reaction?
SIN
ScienceX Information Network (SIN) | ScienceX Innovations
